Arch Partners Iii Lp Three is 10% at ACELRX PHARMACEUTICALS INC (ACRX). They have made 1 open-market trade across 1 company since 2012, most recently 2012-05-29.
CIK 0001256741
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
1 open-market purchase totalling $968K since 2012, never a sale. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| ACRX | 3,958,829 | $3.4M |
Shares reported on the most recent Form 4, priced at the 2012-06-06 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| ACRX | BUY | 2012-05-29 | 2012-06-06 | $3.40 | $968K | -21.8% | -0.4% | -0.4% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.